Vote Scores

Home / Companies / Arcus Biosciences, Inc. / 11 Jun 2026

Meeting · year to 30 June 2026352 filers reporting

Arcus Biosciences, Inc.: meeting of 11 Jun 2026

Votes reported on Form N-PX, item by item

352 Form N-PX filers reported votes at the Arcus Biosciences, Inc. meeting of 11 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

4 nominees; 51.1% of reported votes for; 86 filers withheld from or voted against at least one nominee.

1,052 vote records from 120 filers. 49 of the 120 filers that marked the item either way voted against management.

44.2% for0.0% against55.8% other40.8% against management120 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

550 vote records from 352 filers. 77 of the 337 filers that marked the item either way voted against management. 15 filers reported this item without a management mark.

73.0% for21.6% against5.4% other22.8% against management352 filers92.0% for8.0% against0.0% other8.0% against management125,073,818 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

263 vote records from 120 filers. 11 of the 120 filers that marked the item either way voted against management.

91.7% for7.5% against0.8% other9.2% against management120 filers97.3% for2.6% against0.0% other2.9% against management34,183,977 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *Against *For
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
InvescoForAgainst *For
EquitableForForFor
Charles SchwabSplit or no voteForAgainst *
Nuveen and TIAAAbstain or withhold *ForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeAbstain or withhold *ForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganForForFor
Goldman SachsAbstain or withhold *ForFor
WisdomTreeSplit or no voteForFor
PGIM and PrudentialAbstain or withhold *Against *For
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesForForFor
SEISplit or no voteAgainst *Against *
T. Rowe PriceForForFor
ThriventAbstain or withhold *ForFor
Lincoln FinancialForForFor
VoyaAbstain or withhold *ForFor
First TrustAbstain or withhold *ForFor
Russell InvestmentsSplit or no voteAgainst *Against *
NationwideForForFor
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsAbstain or withholdForFor
Guggenheim and RydexAbstain or withhold *ForFor
Columbia ThreadneedleAbstain or withhold *ForFor
BNY MellonSplit or no voteForFor
PrincipalAbstain or withhold *ForFor
Pacific Life fundsForForFor
Global XSplit or no voteAgainst *Against *
MFSAbstain or withhold *ForFor
AllianceBernsteinNo reportForNo report
Hartford FundsForForFor
DWSAbstain or withhold *ForFor
AllspringAbstain or withhold *ForFor
MassMutualNo reportForNo report
Macquarie and Delaware FundsAbstain or withhold *ForFor
Neuberger BermanNo reportAgainst *No report
Natixis and Loomis SaylesNo reportAgainst *No report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Arcus Biosciences, Inc. meeting?

352 Form N-PX filers reported votes at the meeting of 11 Jun 2026. On say-on-pay, 77 of 337 voted against management (22.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Arcus Biosciences, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Arcus Biosciences, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Arcus Biosciences, Inc. with a meeting date within three days of 11 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.